Postdoc: NF-κB Signaling in Myeloma & MCL

Biopractify; Paris; Hybride; EUR 28 000 - 38 000; Plein temps

Avantages offerts par ce poste

Monthly transport pass (75%)

Résumé du poste

The Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris) invites applications for a Postdoctoral Researcher to investigate NF-κB signaling in hematological malignancies, focusing on multiple myeloma and mantle cell lymphoma. This three-year fixed-term role is funded by INCa and located at the Pitié-Salpêtrière campus in Paris.

You will work in a multidisciplinary environment, using molecular biology, proteomics, and cellular pharmacology, with access to patient samples and

Qualifications

• PhD in Cell Biology, Molecular Biology, Cancer Biology, Pharmacology or related biomedical discipline.
• Experience with cancer biology, immunology, inflammation, infection, NF-κB signaling, proteasome/ubiquitination, or hematology is advantageous.

Responsabilités

• Investigate NF-κB pathway regulation in multiple myeloma and mantle cell lymphoma.
• Identify and characterize novel therapeutic targets affecting NF-κB activation.
• Work with molecular biology, proteomics, and translational research approaches; analyze patient samples.

Formation

PhD in Cell/Molecular/Cancer Biology or Pharmacology

Outils

CRISPR/Cas9

Proteomics

Flow Cytometry

Western Blotting

Cell Culture

Description du poste

The Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris) invites applications for a Postdoctoral Researcher to investigate NF-κB signaling in hematological malignancies, focusing on multiple myeloma and mantle cell lymphoma. This three-year fixed-term role is funded by INCa and located at the Pitié-Salpêtrière campus in Paris.

You will work in a multidisciplinary environment, using molecular biology, proteomics, and cellular pharmacology, with access to patient samples and